RE: Positive discussion with a number of global BioPharma companies" - 10p now???????28 Jan 2025 13:08
The Company is making a significant step towards personalised medicine in SLE and other autoimmune diseases.
(Link: https://www.immupharma.co.uk/news/)
The ImmuPharma team also attended the JP Morgan and Biotech Showcase healthcare conferences earlier this month.
Attending both meetings gave the ImmuPharma team the opportunity to continue positive discussions with a number of global BioPharma companies, that have already expressed an interest in P140 and its unique approach to treating autoimmune diseases.
ImmuPharma is not aware of any further material commercial or operational reason for the significant share price movements, however, the Company will continue to update the market on developments, both commercially and scientifically, when appropriate, ??
the clue is in there some where why the rise ??
he Market won't believe him, that there is nothing going on in the background ??